Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupropion SR for Smokeless Tobacco Use
NCT00414180Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2003
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in Tobacco Use Disorder (TUD), sponsored by Mayo Clinic. Started Aug 2003; status: completed.
02
Drugs
bupropion
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT00414180.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00414180.